Purine Nucleoside Phosphorylase Deficiency Medication Savings with TheDrugClub
Members can check active-formulary eligibility and membership pricing for Purine Nucleoside Phosphorylase Deficiency medications. A condition association alone does not establish coverage.
What Is Purine Nucleoside Phosphorylase Deficiency?
Purine Nucleoside Phosphorylase Deficiency is a medical condition that may require prescription treatment. Consult a healthcare professional about appropriate options.
Managing Purine Nucleoside Phosphorylase Deficiency with TheDrugClub
Eligible medications linked to the active formulary may have no additional cost under listed supply, quantity, fill, and fulfillment limits. Other prescriptions may qualify for membership pricing. Confirm current terms before filling.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
About Purine Nucleoside Phosphorylase Deficiency
Purine Nucleoside Phosphorylase (PNP) deficiency is a rare genetic disorder that severely compromises the immune system, leading to recurrent infections and neurological problems. Managing this condition often involves specialized and costly treatments. TheDrugClub is dedicated to helping individuals and families afford essential medications, making care for conditions like PNP deficiency more accessible.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
About Purine nucleoside phosphorylase deficiency (from MedlinePlus Genetics)
Purine nucleoside phosphorylase deficiency is a disorder of the immune system called an immunodeficiency. Immunodeficiencies are conditions in which the immune system is not able to protect the body effectively from foreign invaders such as bacteria and viruses.
People with purine nucleoside phosphorylase deficiency have low numbers of immune system cells called T cells, which normally recognize and attack foreign invaders to prevent infection. Some affected individuals also have low numbers of other immune system cells called B cells, which normally help fight infections by producing immune proteins called antibodies (or immunoglobulins). These proteins target foreign invaders and mark them for destruction. The most severely affected individuals, who lack T cells and B cells, have a serious condition called severe combined immunodeficiency (SCID).
The shortage of immune system cells in people with purine nucleoside phosphorylase deficiency results in repeated and persistent infections typically beginning in infancy or early childhood. Infections most commonly affect the sinuses and lungs. These infections are often caused by "opportunistic" organisms that ordinarily do not cause illness in people with a normal immune system. The infections can be very serious or life-threatening, and without successful treatment to restore immune function, children with purine nucleoside phosphorylase deficiency usually do not survive past childhood.
Infants with purine nucleoside phosphorylase deficiency typically grow more slowly than healthy babies. About two-thirds of individuals with this condition also have neurological problems, which may include developmental delay, intellectual disability, difficulty with balance and coordination (ataxia), and muscle stiffness (spasticity). People with purine nucleoside phosphorylase deficiency are also at increased risk of developing autoimmune disorders, which occur when the immune system malfunctions and attacks the body's tissues and organs.
Source: MedlinePlus Genetics, U.S. National Library of Medicine
This information is educational and is not medical advice.